Fibrinolysis for acute myocardial infarction - The future is here and now

被引:47
作者
Armstrong, PW
Collen, D
Antman, E
机构
[1] Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB T6G 2H7, Canada
[2] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium
[3] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1161/01.CIR.0000072930.64775.DC
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2533 / 2537
页数:5
相关论文
共 28 条
[1]  
ANDERSON HR, 2002, AM COLL CARD ANN SCI
[2]   Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: A substudy of the GUSTO-III trial [J].
Anderson, RD ;
White, HD ;
Ohman, EM ;
Wagner, GS ;
Krucoff, MW ;
Armstrong, PW ;
Weaver, WD ;
Gibler, WB ;
Stebbins, AL ;
Califf, RM ;
Topol, EJ .
AMERICAN HEART JOURNAL, 2002, 144 (01) :81-88
[3]   Abciximab facilitates the rate and extent of thrombolysis - Results of the thrombolysis in myocardial infarction (TIMI) 14 trial [J].
Antman, EM ;
Giugliano, RP ;
Gibson, CM ;
McCabe, CH ;
Coussement, P ;
Kleiman, NS ;
Vahanian, A ;
Adgey, AAJ ;
Menown, I ;
Rupprecht, HJ ;
Van der Wieken, R ;
Ducas, J ;
Scherer, J ;
Anderson, K ;
Van de Werf, F ;
Braunwald, E .
CIRCULATION, 1999, 99 (21) :2720-2732
[4]   Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction - Results of the ENTIRE-thrombolysis in myocardial infarction (TIMI) 23 trial [J].
Antman, EM ;
Louwerenburg, HW ;
Baars, HF ;
Wesdorp, JCL ;
Hamer, B ;
Bassand, JP ;
Bigonzi, F ;
Pisapia, G ;
Gibson, CM ;
Heidbuchel, H ;
Braunwald, E ;
Van de Werf, F .
CIRCULATION, 2002, 105 (14) :1642-1649
[5]   INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS [J].
APPLEBY, P ;
BAIGENT, C ;
COLLINS, R ;
FLATHER, M ;
PARISH, S ;
PETO, R ;
BELL, P ;
HALLS, H ;
MEAD, G ;
DIAZ, R ;
PAOLASSO, E ;
PAVIOTTI, C ;
ROMERO, G ;
CAMPBELL, T ;
OROURKE, MF ;
THOMPSON, P ;
LESAFFRE, E ;
VANDEWERF, F ;
VERSTRAETE, M ;
ARMSTRONG, PW ;
CAIRNS, JA ;
MORAN, C ;
TURPIE, AG ;
YUSUF, S ;
GRANDE, P ;
HEIKKILA, J ;
KALA, R ;
BASSAND, JP ;
BOISSEL, JP ;
BROCHIER, M ;
LEIZOROVICZ, A ;
BRUGGEMANN, T ;
KARSCH, KR ;
KASPER, W ;
LAMMERTS, D ;
NEUHAUS, KL ;
MEYER, J ;
SCHRODER, R ;
VONESSEN, R ;
SARAN, RK ;
ARDISSINO, D ;
BONADUCE, D ;
BRUNELLI, C ;
CERNIGLIARO, C ;
FORESTI, A ;
FRANZOSI, MG ;
GUIDUCCI, D ;
MAGGIONI, A ;
MAGNANI, B ;
MATTIOLI, G .
LANCET, 1994, 343 (8893) :311-322
[6]  
Armstrong PW, 2001, CIRCULATION, V103, P2862
[7]   Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, part 2 [J].
Armstrong, PW ;
Collen, D .
CIRCULATION, 2001, 103 (24) :2987-2992
[8]  
AVERSANO T, JAMA, V287, P1943
[9]   Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour [J].
Boersma, E ;
Maas, ACP ;
Deckers, JW ;
Simoons, ML .
LANCET, 1996, 348 (9030) :771-775
[10]   Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study [J].
Bonnefoy, E ;
Lapostolle, F ;
Leizorovicz, A ;
Steg, G ;
McFadden, EP ;
Dubien, PY ;
Cattan, S ;
Boullenger, E ;
Machecourt, J ;
Lacroute, JM ;
Cassagnes, J ;
Dissait, F ;
Touboul, P .
LANCET, 2002, 360 (9336) :825-829